Abstract

Asperger Syndrome (AS) is a neurodevelopmental condition characterized by impairments in social interaction and communication, alongside the presence of unusually repetitive, restricted interests and stereotyped behaviour. Individuals with AS have no delay in cognitive and language development. It is a subset of Autism Spectrum Conditions (ASC), which are highly heritable and has a population prevalence of approximately 1%. Few studies have investigated the genetic basis of AS. To address this gap in the literature, we performed a genome-wide pooled DNA association study to identify candidate loci in 612 individuals (294 cases and 318 controls) of Caucasian ancestry, using the Affymetrix GeneChip Human Mapping version 6.0 array. We identified 11 SNPs that had a p-value below 1x10-5. These SNPs were independently genotyped in the same sample. Three of the SNPs (rs1268055, rs7785891 and rs2782448) were nominally significant, though none remained significant after Bonferroni correction. Two of our top three SNPs (rs7785891 and rs2782448) lie in loci previously implicated in ASC. However, investigation of the three SNPs in the ASC genome-wide association dataset from the Psychiatric Genomics Consortium indicated that these three SNPs were not significantly associated with ASC. The effect sizes of the variants were modest, indicating that our study was not sufficiently powered to identify causal variants with precision.

Highlights

  • Asperger Syndrome (AS) is a neurodevelopmental condition and a subset of Autism Spectrum Conditions (ASC) [1]

  • All cases were recruited from the Cambridge Autism Research Database (CARD) at www.autismresearchcentre.com, and reported that they had a clinical diagnosis of AS according to DSM IV or ICD-10 criteria

  • This correlation is considerably higher than another study that used pooled DNA obtained from cheek swabs on the same platform, though lower than the correlation reported for DNA obtained from blood samples [24]

Read more

Summary

A Pooled Genome-Wide Association Study of Asperger Syndrome

Varun Warrier1‡*, Bhismadev Chakrabarti1,2‡, Laura Murphy, Allen Chan, Ian Craig, Uma Mallya, Silvia Lakatošová, Karola Rehnstrom, Leena Peltonen4†, Sally Wheelwright, Carrie Allison, Simon E. Data Availability Statement: Summary data has been provided in the manuscript. Due to ethical restrictions related to patient consent, individual-level data are available upon request to Varun Warrier (vw260@medschl.cam.ac.uk).

Introduction
Participants
Results
Discussion
American Psychiatric Association

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.